EU Accelerates Medtech Regulatory Reform Process
This article was originally published in The Gray Sheet
Executive Summary
Recent votes suggest a possible acceleration in the negotiation process on European reforms to device and diagnostic regulatory oversight on the continent.
You may also be interested in...
EU Council Resists Parliament Pressure To Pick Up The Pace On Reforms
The body representing European Union country heads of state continues to lag well behind the European Parliament progress on comprehensive device and diagnostic regulatory reforms, and is resistant to nudges to speed things up.
EU Device Reform Proposal Adds More Government Scrutiny, But No FDA-Like Review Body
The recommendation attracting the most concern from industry: a new Medical Device Coordination Group that would have the option to scrutinize third-party pre-market assessment reports for select devices prior to marketing.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.